Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA
- Status
- UNKNOWN
- Phase
- N/A
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE
- Status
- WITHDRAWN
- Phase
- PHASE2
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression
- Status
- TERMINATED
- Phase
- PHASE2
Low Pressure Pneumoperitoneum and Deep Neuromuscular Block vs. Standard During RARP to Improve Quality of Recovery; a Randomized Controlled Study.
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection
- Status
- WITHDRAWN
- Phase
- PHASE3
Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)
- Status
- WITHDRAWN
- Phase
- PHASE4
Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)
- Status
- COMPLETED
- Phase
- PHASE3
Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)
- Status
- COMPLETED
- Phase
- PHASE3
Pembrolizumab in Early Stage Colon Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Ertugliflozin for Functional Mitral Regurgitation
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Longitudinal Immune-phenotyping of HCC Following MK-3475
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1